INOVIQ Ltd
ASX:IIQ

Watchlist Manager
INOVIQ Ltd Logo
INOVIQ Ltd
ASX:IIQ
Watchlist
Price: 0.355 AUD Market Closed
Market Cap: AU$50m

Relative Value

The Relative Value of one IIQ stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.355 AUD, INOVIQ Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IIQ Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

IIQ Competitors Multiples
INOVIQ Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
INOVIQ Ltd
ASX:IIQ
50m AUD 52.1 -7.2 -6.3 -6.3
US
CVS Health Corp
NYSE:CVS
96B USD 0.2 204.7 13.6 13.6
US
Cigna Corp
NYSE:CI
72.7B USD 0.3 11.8 0 0
US
Cigna Group
XMUN:CGN
60.8B EUR 0.3 11.6 8.9 11.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR 1.2 23.7 10.4 15.7
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR 1.1 30.9 9.9 21.1
US
Laboratory Corporation of America Holdings
NYSE:LH
22.2B USD 1.6 26 14 19.6
US
Quest Diagnostics Inc
NYSE:DGX
20.7B USD 1.9 21.1 11.6 15.7
US
Guardant Health Inc
NASDAQ:GH
14.3B USD 15.9 -36.1 -37.9 -34.4
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.1B EUR 0.6 15.5 6.2 13.2
US
DaVita Inc
NYSE:DVA
7.8B USD 0.6 10.1 6.5 8.9
P/E Multiple
Earnings Growth PEG
AU
INOVIQ Ltd
ASX:IIQ
Average P/E: 39.5
Negative Multiple: -7.2
N/A N/A
US
CVS Health Corp
NYSE:CVS
204.7
32%
6.4
US
Cigna Corp
NYSE:CI
11.8
39%
0.3
US
C
Cigna Group
XMUN:CGN
11.6
39%
0.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.7
71%
0.3
DE
Fresenius Medical Care AG
XMUN:FME
30.9
37%
0.8
US
Laboratory Corporation of America Holdings
NYSE:LH
26
30%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
21.1
14%
1.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -36.1 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
15.5
37%
0.4
US
DaVita Inc
NYSE:DVA
10.1
4%
2.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
INOVIQ Ltd
ASX:IIQ
Average EV/EBITDA: 10.1
Negative Multiple: -6.3
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.6
25%
0.5
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
8.9
4%
2.2
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.4
14%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
9.9
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
14
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
11.6
8%
1.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -37.9 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.2
10%
0.6
US
DaVita Inc
NYSE:DVA
6.5
4%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
INOVIQ Ltd
ASX:IIQ
Average EV/EBIT: 14.9
Negative Multiple: -6.3
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.6
19%
0.7
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
11.3
5%
2.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.7
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
21.1
25%
0.8
US
Laboratory Corporation of America Holdings
NYSE:LH
19.6
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.7
11%
1.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -34.4 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.2
25%
0.5
US
DaVita Inc
NYSE:DVA
8.9
4%
2.2